FDA.reportPublic FDA data

0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys]

RxCUI
731328
RxNorm name
0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys]
Display name
0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys]
Full name
0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103964Pegasyspeginterferon alfa-2a351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PegasysPEGINTERFERON ALFA-2Apharmaand GmbHd9290e5b-6d40-2318-e053-2995a90a99162026-09-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 731328

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d9290e5b-6d40-2318-e053-2995a90a9916Pegasys 180 MCG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys] [SBD] · 0.5 ML Pegasys 0.36 MG/ML Prefilled Syringe [SY] · Pegasys 180 MCG per 0.5 ML Prefilled Syringe [SY]444These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 200220250811